Human Recombinant CD109 protein, His Tag (V2LY-0526-LY2656)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Expressed Host
HEK293 Cells
Protein Species
Human
Tag
His Tag
Protein Construction
This product is Human Recombinant CD109 protein, His Tag consist of Amino Acid: 1-1269 and predicts a molecular mass of 141.23 kDa.
Molecule Mass
141.23 kDa
Verified
HPLC
Sequence
Amino Acid: 1-1269
Species
Human

Formulations & Storage [For reference only, actual COA shall prevail!]

Purity
≥90% as determined by SDS-PAGE. ≥85% as determined by SEC-HPLC.
Endotoxin
Please contact us for more information.
Format
Lyophilized
Reconstitution
Allow the vial and reconstitution buffer to equilibrate to room temperature. Briefly centrifuge or tap down the vial to ensure that all lyophilized powder is collected at the bottom of the vial. For the reconstitution of this product, we recommend adding PBS or sterile water to achieve a final antibody concentration of 1 mg/mL. Allow the vial to reconstitute for 10-15 minutes at room temperature with gentle agitation. Avoid vigorous shaking that can cause foaming and antibody denaturation. Aliquot into volumes based on your experiment and store liquid protein at -20°C or -80°C for long time.
Buffer
Lyophilized from sterile PBS
Preservative
None
Storage
Samples are stable for up to twelve months from date of receipt at -20°C to -80°C. Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
More Infomation

Target

Full Name
CD109 Molecule
Function
Modulates negatively TGFB1 signaling in keratinocytes.
Biological Process
Hair follicle development Source: Ensembl
Negative regulation of keratinocyte proliferation Source: Ensembl
Negative regulation of protein phosphorylation Source: Ensembl
Negative regulation of transforming growth factor beta receptor signaling pathway Source: UniProtKB
Negative regulation of wound healing Source: UniProtKB
Osteoclast fusion Source: Ensembl
Platelet degranulation Source: Reactome
Regulation of keratinocyte differentiation Source: Ensembl
Cellular Location
Cell membrane
PTM
N-glycosylated.
2 forms of 150 (p150) and 120 kDa (p120) exist due to proteolytic degradation from a 180 kDa form.

Merle, N. S., Kolev, M., Rahman, J., West, E., Yan, B., Kazemian, M., ... & Kemper, C. (2021). The C3-like molecule CD109 controls Th1 versus Th17 induction in CD4+ T cells.

Lee, K. Y., Kuo, T. C., Chou, C. M., Hsu, W. J., Lee, W. C., Dai, J. Z., ... & Lin, C. W. (2021). Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling. Cells, 10(1), 28.

Li, C., Cho, H. J., Yamashita, D., Abdelrashid, M., Chen, Q., Bastola, S., ... & Nakano, I. (2020). Tumor edge-to-core transition promotes malignancy in primary-to-recurrent glioblastoma progression in a PLAGL1/CD109-mediated mechanism. Neuro-oncology advances, 2(1), vdaa163.

Lee, K. Y., Shueng, P. W., Chou, C. M., Lin, B. X., Lin, M. H., Kuo, D. Y., ... & Lin, C. W. (2020). Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR‐AKT‐mTOR signaling. Cancer science, 111(5), 1652.

Hatsuzawa, Y., Yamaguchi, K., Takanashi, T., Sato, I., Tamai, K., Mochizuki, M., ... & Sugamura, K. (2020). CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells. Pancreatology, 20(3), 493-500.

Zhou, S., da Silva, S. D., Siegel, P. M., & Philip, A. (2019). CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro. Scientific reports, 9(1), 1-17.

Mii, S., Enomoto, A., Shiraki, Y., Taki, T., Murakumo, Y., & Takahashi, M. (2019). CD109: a multifunctional GPI‐anchored protein with key roles in tumor progression and physiological homeostasis. Pathology international, 69(5), 249-259.

Qi, R., Dong, F., Liu, Q., Murakumo, Y., & Liu, J. (2018). CD109 and squamous cell carcinoma. Journal of translational medicine, 16(1), 1-8.

Chuang, C. H., Greenside, P. G., Rogers, Z. N., Brady, J. J., Yang, D., Ma, R. K., ... & Winslow, M. M. (2017). Molecular definition of a metastatic lung cancer state reveals a targetable CD109–Janus kinase–Stat axis. Nature medicine, 23(3), 291-300.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human Recombinant CD109 protein, His Tag?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.